The North America Infectious Disease Diagnostics Market was valued at USD 8.98 Billion in 2025 and is expected to reach USD 15.39 Billion by 2033, growing at a CAGR of 6.9% (2026-2033).

Veterinary Point of Care Diagnostics Market is set to rise from USD 2.9 Billion in 2025 to USD 5.9 Billion by 2033, fueled by rapid testing demand, gr...

Hospital Acquired Infections Diagnostics Market to grow from USD 4.2B in 2025 to USD 7.3B by 2035, at a CAGR of 7.1% over the next decade.

The STD diagnostics market will grow from $8.5B in 2025 to $16.8B by 2033, driven by rising awareness, with a projected CAGR of 9.0% over the decade

The Global Cardiac AI Monitoring and Diagnostics Market was valued at USD 1.49 Billion in 2024 and is expected to reach USD 7.70 Billion by 2032, growing at a CAGR of 2.28% (2025-2032).

The Global Cancer Diagnostics Market was valued at USD 110.11 Billion in 2024 and is expected to reach USD 199.32 Billion by 2032, growing at a CAGR of 7.7% (2025-2032).

The North America Bladder Cancer Diagnostics Market was valued at USD 1,591.09 million in 2023 and is expected to reach USD 0.00 million by 2030, growing at a CAGR of 9.1% (2024-2030).

The Middle East and Africa Bladder Cancer Diagnostics Market was valued at USD 0.00 in 2023 and is expected to reach USD 210.82 by 2030, growing at a CAGR of 6.7% (2024-2030).

The Europe Bladder Cancer Diagnostics Market was valued at USD 0.00 in 2023 and is expected to reach USD 1,176.54 by 2030, growing at a CAGR of 8% (2024-2030).